Skip to main content

Table 1 Clinical characteristics of subjects divided by serum amylase levels

From: Latent associations of low serum amylase with decreased plasma insulin levels and insulin resistance in asymptomatic middle-aged adults

 

Low serum amylase (< 60 IU/ml)

Normal to high serum amylase (≥ 60 IU/ml)

P values

n

21

33

Age

47.1 ± 7.3

49.6 ± 7.8

0.22

Men, n (%)

17 (81.0)

27 (81.8)

0.93

Body mass index (kg/m2)

25.5 ± 3.9

23.4 ± 2.6

0.04

Systolic blood pressure (mmHg)

119 ± 18.5

118 ± 15.0

0.88

Diastolic blood pressure (mmHg)

71.9 ± 11.6

73.8 ± 11.5

0.54

Triglyceride (mg/dl)

117 (88-184)

92 (76-125)

0.17

HDL-cholesterol (mg/dl)

55.9 ± 16.1

54.8 ± 10.7

0.96

Creatinine (mg/dl)

0.8 ± 0.2

0.8 ± 0.1

0.93

eGFR (ml/min/1.73 m2)

84.8 ± 16.9

80.5 ± 11.1

0.56

Amylase (IU/l)

49.4 ± 7.6

74.6 ± 14.1

(range)

(32–59)

(60–121)

HbA1c (%) (NGSP)

5.7 ± 0.3

5.6 ± 0.3

0.47

FPG (mg/dl)

102 ± 11

98 ± 7.6

0.32

PG at 60 min (mg/dl)*

144 ± 40

138 ± 33

0.56

PG at 120 min (mg/dl)*

151 ± 44

119 ± 35

0.004

FPI (μU/ml)

6.0 (3.6–14.9)

10.3 (5.1–13.1)

0.30

PI at 60 min (μU/ml)*

32.2 (18.7–62.1)

55.3 (41.7–86.3)

0.06

PI at 120 min (μU/ml)*

47.3 (31.6–102)

45.4 (29.0–65.6)

0.67

HOMA-R

1.5 (0.9–3.9)

2.3 (1.2–3.4)

0.45

QUICKI

0.38 ± 0.10

0.34 ± 0.04

0.45

HOMA-β

57.6 (34–125)

104 (54-138)

0.10

Leptin (pg/ml)

37.3 (18–55)

27.9 (18–43)

0.40

TNFα (pg/ml)

0.69 (0.5–1.1)

0.56 (0.5–0.7)

0.08

Type 2 diabetes

4

1

0.13

Current smokers, n (%)

6 (28.6)

11 (33.3)

0.95

Everyday alcohol drinkers, n (%)

10 (47.6)

9 (27.3)

0.19

Regular exerciser, n (%)

3 (14.3)

7 (21.2)

0.78

  1. Data are means ± SD or medians (interquartile range) for highly skewed variables.
  2. Continuous variables and categorical valuables were compared using the Mann–Whitney test and χ2-test, respectively.
  3. *Measured during a 75-g OGTT.
  4. Five subjects were suspected of having type 2 diabetes because PG at 120 min was ≥ 200 mg/dl.
  5. eGFR: estimated glomerular filtration rate; FPG: fasting plasma glucose; FPI: fasting plasma insulin; HDL-C: high-density lipoprotein; HOMA: homeostasis model assessment; OGTT: oral glucose tolerance test; NGSP; National Glycohemoglobin Standardization Program; PG: plasma glucose; PI: plasma insulin; QUICKI: quantitative insulin sensitivity check index; regular exerciser: subjects who exercise over 30 minutes at least twice per week; TNF α: tumor necrosis factor α.